Amphastar Pharmaceuticals, Inc. - COM (AMPH)

Historical Portfolio Holders from Q2 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
35.3M
Holdings value Q3 2024
$1.71B
Value change Q3 2024
+$41.7M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
274
Number of buys Q3 2024
133
Number of sells Q3 2024
-125
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 35.3M $1.71B +$41.7M $48.53 274
2024 Q2 34.4M $1.38B +$32.8M $40.00 267
2024 Q1 33.5M $1.47B -$571K $43.91 268
2023 Q4 33.3M $2.06B +$87.2M $61.85 272
2023 Q3 32M $1.47B +$20.4M $45.99 251
2023 Q2 31.4M $1.8B +$73.8M $57.47 239
2023 Q1 30.2M $1.13B +$45M $37.50 215
2022 Q4 29.1M $817M -$23.4M $28.02 207
2022 Q3 29.9M $839M -$35.8M $28.10 194
2022 Q2 30.6M $1.06B +$41M $34.79 218
2022 Q1 29.8M $1.07B +$25.9M $35.90 203
2021 Q4 29.2M $679M +$19.6M $23.29 165
2021 Q3 27.9M $531M +$12.2M $19.01 136
2021 Q2 27.3M $550M +$25.7M $20.16 142
2021 Q1 26M $477M +$545K $18.32 129
2020 Q4 26M $523M -$2.78M $20.11 126
2020 Q3 26.2M $492M -$4.78M $18.75 131
2020 Q2 26.3M $591M +$55.5M $22.46 132
2020 Q1 23.9M $355M -$14.2M $14.84 105
2019 Q4 24.6M $474M +$9.59M $19.29 116
2019 Q3 24.1M $478M +$39.1M $19.83 130
2019 Q2 22.3M $471M +$11.7M $21.11 129
2019 Q1 22.4M $458M +$3.99M $20.43 133
2018 Q4 22.2M $442M +$31.4M $19.90 129
2018 Q3 20.6M $397M +$12M $19.24 104
2018 Q2 20.1M $307M -$10.1M $15.26 110
2018 Q1 20.7M $388M +$4.86M $18.75 114
2017 Q4 20.6M $397M +$6.68M $19.24 105
2017 Q3 20.2M $362M -$3.14M $17.87 99
2017 Q2 20.4M $365M +$4.54M $17.86 107
2017 Q1 20.4M $296M +$42.3M $14.50 113
2016 Q4 22.3M $412M +$7.35M $18.42 135
2016 Q3 22.2M $421M +$115M $18.97 134
2016 Q2 16.2M $261M +$32.1M $16.12 105
2016 Q1 14.3M $171M -$8.85M $12.00 94
2015 Q4 14.7M $210M +$12.9M $14.23 93
2015 Q3 12.1M $141M -$3.14M $11.69 90
2015 Q2 13.3M $234M +$48.8M $17.58 85
2015 Q1 10.6M $158M +$40.4M $14.96 57
2014 Q4 7.93M $92.1M +$5.4M $11.61 54
2014 Q3 7.24M $84.4M +$80.9M $11.64 44
2014 Q2 300K $3M +$3M $10.01 2